Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and Granulocytic Leukemia, Chronic

isoxazoles has been researched along with Granulocytic Leukemia, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, EJ; Hyun, SK; Kang, CD; Kim, HB; Kim, MJ; Kim, SH; Lee, SH; Oh, WK; Um, JH1
Ashihara, E; Kimura, S; Maekawa, T; Ohyashiki, K; Okabe, S; Tauchi, T1
Avery, RK; Bolwell, BJ; Curtis, J; Kalaycio, M; Kohn, D; Long, JR; Longworth, DL; Lurain, N; Mossad, SB; Pohlman, B; Taege, AJ; Waldman, WJ; Williams, JW; Yen-Lieberman, B1

Other Studies

3 other study(ies) available for isoxazoles and Granulocytic Leukemia, Chronic

ArticleYear
Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.
    International journal of biological sciences, 2015, Volume: 11, Issue:8

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzoquinones; Carbazoles; Dibenzocycloheptenes; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; K562 Cells; Lactams, Macrocyclic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Proteins; Neoplastic Stem Cells; Resorcinols; Sirtuin 1; Up-Regulation

2015
Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen.
    Oncogene, 2011, Jun-16, Volume: 30, Issue:24

    Topics: Animals; Benzamides; Cell Line, Tumor; Fusion Proteins, bcr-abl; HSP90 Heat-Shock Proteins; Humans; Imatinib Mesylate; Isoxazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mutagenesis; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Resorcinols

2011
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
    Bone marrow transplantation, 2004, Volume: 34, Issue:12

    Topics: Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Fatal Outcome; Female; Foscarnet; Graft vs Host Disease; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure; Middle Aged; Salvage Therapy; Transplantation, Homologous; Viral Load

2004